25-hydroxyprotopanaxadiol has been researched along with thioacetamide in 1 studies
| Studies (25-hydroxyprotopanaxadiol) | Trials (25-hydroxyprotopanaxadiol) | Recent Studies (post-2010) (25-hydroxyprotopanaxadiol) | Studies (thioacetamide) | Trials (thioacetamide) | Recent Studies (post-2010) (thioacetamide) |
|---|---|---|---|---|---|
| 21 | 0 | 19 | 1,705 | 4 | 655 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, T; Su, G; Zhao, Y | 1 |
1 other study(ies) available for 25-hydroxyprotopanaxadiol and thioacetamide
| Article | Year |
|---|---|
Anti-hepatic fibrosis effects of AD-2 affecting the Raf-MEK signaling pathway and inflammatory factors in thioacetamide-induced liver injury.
Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Ginsenosides; Inflammation; Liver Cirrhosis; Male; Mice; Mitogen-Activated Protein Kinase Kinases; Panax; raf Kinases; Signal Transduction; Thioacetamide | 2021 |